Merck的股票创下12个月的高价 收入丰厚, 买入升级, 尽管缺少估计。 Merck's stock hit a 12-month high on strong earnings and a buy upgrade, despite missing estimates.

Merck & Co. (MRK)股份在2026年2月3日创下12个月的113.89美元高峰, Merck & Co. (MRK) shares hit a 12-month high of $113.89 on February 3, 2026, following a strong earnings report and a stock upgrade to strong-buy from Wall Street Zen. 该公司报告第四季度收入为每股1.94美元,略低于2.08美元的估计数,但股本回报率为44.54%,净利润率为29.63%。 The company reported fourth-quarter earnings of $1.94 per share, slightly below the $2.08 estimate, but maintained a 44.54% return on equity and 29.63% net margin. Merck将其2026年全年收入指导提高到每股5.00-5.15美元,低于分析师的预期。 Merck raised its full-year 2026 earnings guidance to $5.00–$5.15 per share, below analyst expectations. 股票的市场上限为281.56亿美元,其交易额为14.99美元,公司宣布季度股息为0.85美元,收益率为3.0%。 The stock, with a market cap of $281.56 billion, is trading at a P/E of 14.99, and the company declared a quarterly dividend of $0.85, yielding 3.0%.